BRAF and thyroid cancer, nonmedullary, 2: Initiating mutations or gene fusions in the thyroid carcinoma include: BRAF in PTC, N-K-H-RAS in PTC and/or follicular thyroid carcinoma (FTC), RET/PTC in PTC, and PAX8/PPARγ in FTC [16].